Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Cardiovascular & Metabolic Sciences,
Lerner Research Institute,
Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute
Defne Bayik has not added Biography.
If you are Defne Bayik and would like to personalize this page please email our Author Liaison for assistance.
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.
JCI insight 11, 2018 | Pubmed ID: 30385717
Development of a Cx46 Targeting Strategy for Cancer Stem Cells.
Cell reports 04, 2019 | Pubmed ID: 31018124
IL-11 drives postsurgical hepatocellular carcinoma recurrence.
EBioMedicine 09, 2019 | Pubmed ID: 31402232
ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells.
Cancer discovery 11, 2019 | Pubmed ID: 31434712
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells.
JCI insight 11, 2019 | Pubmed ID: 31600167
MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.
Molecular metabolism 04, 2020 | Pubmed ID: 32180553
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.
Cancer discovery 08, 2020 | Pubmed ID: 32300059
Release the ballast: Glioblastoma rises above radiation therapy by exporting miR-603 in extracellular vesicles to become treatment-resistant.
EBioMedicine 06, 2020 | Pubmed ID: 32502962
JAM-A functions as a female microglial tumor suppressor in glioblastoma.
Neuro-oncology 11, 2020 | Pubmed ID: 32592484
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Frontiers in immunology , 2020 | Pubmed ID: 32625208
Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response.
Journal of controlled release : official journal of the Controlled Release Society 12, 2020 | Pubmed ID: 32971199
Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles.
Scientific reports 11, 2020 | Pubmed ID: 33139767
High-Dimensional Analysis of Circulating and Tissue-Derived Myeloid-Derived Suppressor Cells from Patients with Glioblastoma.
Methods in molecular biology (Clifton, N.J.) , 2021 | Pubmed ID: 33237547
Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2021 | Pubmed ID: 33542075
Cancer stem cell-immune cell crosstalk in tumour progression.
Nature reviews. Cancer 08, 2021 | Pubmed ID: 34103704
Cleveland Clinic
Dionysios C. Watson1,2,3,
Sadie Johnson1,
Akeem Santos1,4,
Mei Yin5,
Defne Bayik1,
Justin D. Lathia1,3,
Mohammed Dwidar1,3,4
1Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic,
2, University Hospitals Cleveland Medical Center,
3, Case Western Reserve University,
4Center for Microbiome & Human Health, Cleveland Clinic,
5Electron Microscopy Core, Lerner Research Institute, Cleveland Clinic
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır